MOLECULAR DOCKING AND COMPUTATIONAL PHARMACOKINETIC STUDY OF SOME NOVEL COUMARIN–BENZOTHIAZOLE SCHIFF’S BASE FOR ANTIMICROBIAL ACTIVITY

BURHANUDDIN MADRIWALA; JUDY JAYS; G. CHAITANYA SAI

doi:10.22159/ijpps.2022v14i8.45046

Authors

BURHANUDDIN MADRIWALA Department of Pharmaceutical Chemistry, M. S. Ramaiah University of Applied Sciences, Bengaluru 560054, Karnataka, India https://orcid.org/0000-0002-3872-0199
JUDY JAYS Department of Pharmaceutical Chemistry, M. S. Ramaiah University of Applied Sciences, Bengaluru 560054, Karnataka, India
G. CHAITANYA SAI Department of Pharmaceutical Chemistry, M. S. Ramaiah University of Applied Sciences, Bengaluru 560054, Karnataka, India https://orcid.org/0000-0002-6018-0416

DOI:

https://doi.org/10.22159/ijpps.2022v14i8.45046

Keywords:

Coumarin, Benzothiazole, Discovery studio, PyRx, DNA ligase, Topoisomerase, Sterol demethylase, Glutamate racemase, Enoyl-Acyl-carrier protein, Molecular docking, Antimicrobial activity

Abstract

Objective: The present study discusses molecular docking of some novel coumarin–benzothiazole Schiff bases and the prediction of pharmacokinetic properties of potent molecules by the computational method.

Methods: Five protein targets were selected for the study and their structures were taken from RCSB Protein Data Bank in PDB format. Preparation of proteins was done using Discovery Studio 2021 Client. A total of twenty derivatives were drawn using ChemDraw 20.0 and saved in Mol format. Molecular docking was performed using PyRx software. Docking results were visualized by Discovery Studio 2021 Client. The pharmacokinetic properties of the best compounds were determined using the pkCSM tool.

Results: All twenty derivatives were docked against the five proteins, namely DNA Ligase (PDB ID: 3PN1), Topoisomerase (PDB ID: 3TTZ), Sterol demethylase (PDB ID: 5FSA), Enoyl-acyl-carrier protein (PDB ID: 1BVR) and Glutamate racemase (PDB ID: 5HJ7). The compound JJB18 has shown the best binding score against DNA ligase (-10.7 kcal/mol), Glutamate racemase (-8.4 kcal/mol), and Enoyl-acyl-carrier protein (-10.8 kcal/mol). Further, compound JJB19 has shown the best score for fungal sterol demethylase (-10.6 kcal/mol) and compound JJB20 towards topoisomerase (-9.4 kcal/mol) than the standard drugs. The physicochemical properties of potent derivatives were also reported.

Conclusion: Molecular Docking study indicates that coumarin–benzothiazole Schiff bases may be effective inhibitors for the different microbial proteins. Additionally, in silico ADMET studies predicts drug-like features. Hence, these compounds may be considered lead molecules and further investigation of their analogues may help in the development of novel drugs for the treatment of microbial diseases.

Downloads

Download data is not yet available.

References

Hay SI, Rao PC, Dolecek C, Day NPJ, Stergachis A, Lopez AD. Measuring and mapping the global burden of antimicrobial resistance. BMC Med. 2018 Jun 4;16(1):78. doi: 10.1186/s12916-018-1073-z, PMID 29860943.

Abushaheen MA, Muzaheed, Fatani AJ, Alosaimi M, Mansy W, George M. Antimicrobial resistance, mechanisms and its clinical significance. Dis Mon. 2020;66(6):100971. doi: 10.1016/j.disamonth.2020.100971. PMID 32201008.

Bhaskar P, Ramachandraiah A. Synthesis, spectral and molecular modelling studies of coumarin derivatives. Int J Curr Pharm Res. 2017:9(3):127. doi: 10.22159/ijcpr.v9i3.19984.

Pappachen L, Zachariah S, Chandran D. In silico design, synthesis and characterization of some novel benzothiazole derivatives as anticancer agents. Asian J Pharm Clin Res. 2017:10(4):150. doi: 10.22159/ajpcr.2017.v10i4.16407.

Divya K, Pinto GM, Pinto AF. Application of metal complexes of Schiff bases as an antimicrobial drug: a review of recent works. Int J Curr Pharm Sci. 2017;9(3):27. doi: 10.22159/ijcpr.2017.v9i3.19966.

Bank R. RCSB PDB: homepage. 2022. Available from: https://www.rcsb.org. [Last accessed on 19 May 2022]

Morsy MA, Ali EM, Kandeel M, Venugopala KN, Nair AB, Greish K. Screening and molecular docking of novel benzothiazole derivatives as potential antimicrobial agents. Antibiotics (Basel). 2020 Apr 29;9(5):221. doi: 10.3390/antibiotics9050221, PMID 32365587.

Sharma PC, Bansal KK, Deep A, Pathak M. Benzothiazole derivatives as potential anti-infective agents. Curr Top Med Chem. 2017 Jan 1;17(2):208-37. doi: 10.2174/1568026616666160530152546, PMID 27237334.

Qin HL, Zhang ZW, Ravindar L, Rakesh KP. Antibacterial activities with the structure-activity relationship of coumarin derivatives. Eur J Med Chem. 2020 Dec 1;207:112832. doi: 10.1016/j.ejmech.2020.112832. PMID 32971428.

Khan MS, Agrawal R, Ubaidullah M, Hassan MI, Tarannum N. Design, synthesis and validation of anti-microbial coumarin derivatives: an efficient green approach. Heliyon. 2019 Oct 18;5(10):e02615. doi: 10.1016/j.heliyon.2019.e02615, PMID 31692746.

Alshibl HM, Al-Abdullah ES, Haiba ME, Alkahtani HM, Awad GEA, Mahmoud AH. Synthesis and evaluation of new coumarin derivatives as antioxidant, antimicrobial, and anti-inflammatory Agents. Molecules. 2020 Jul 16;25(14):3251. doi: 10.3390/molecules25143251, PMID 32708787.

Ashok D, Ramakrishna K, Nagaraju N, Reddy MR, Dharavath R, Sarasija M. Microwave-assisted synthesis of substituted 2-(2H-Chromen-3-yl)-5-phenyl-1H-imidazole based coumarin derivatives and their antimicrobial activity. Russ J Gen Chem. 2021 May 21;91(4):711-6. doi: 10.1134/S1070363221040216.